Use Google SSO for the fastest sign-in experience across IP news, saved access limits, and member-only newsroom features. You can still choose another login method if you prefer.
Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.
1 article published on this day, newest first.
Catalyst Pharmaceuticals and Lupin have settled a legal dispute related to Lupin’s generic version of Firdapse (amifampridine) — an approved brand-na…
Catalyst Pharmaceuticals and Lupin have settled a legal dispute related to Lupin’s generic version of Firdapse (amifampridine) — an approved brand-name treatment for Lambert-Eaton myasthenic syndrome (LEMS).
Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.
Catalyst Pharmaceuticals and Lupin have settled a legal dispute related to Lupin’s generic version of Firdapse (amifampridine) — an approved brand-name treatment for Lambert-Eaton myasthenic syndrome (LEMS).
Leading medical technology company Becton Dickinson and Company (BD) has filed a patent infringement lawsuit against Baxter International Inc., claiming that Baxter has unlawfully used BD’s patented technologies in it...
Regularly check our site to learn about PCT filing and more crucial ideas. The patent Cooperation Treaty is known as PCT. It is an international agreement that has more than 150 members. Submitting a single PCT applic...
IIPLA News reviews a fresh appellate development affecting timing strategy and disclaimer analysis in pharmaceutical patent litigation.
Intellectual property (IP) is an essential component of any high-tech start-up's business strategy. However, navigating the complex landscape of IP law can be challenging, and there are many potential pitfalls that st...
Customs and Border Protection (CBP) authorities around the world are stepping up their efforts to combat the growing threat of intellectual property (IP) theft. IP theft, which involves the unauthorized use or copying...